Baillie Gifford & Co
MRK icon

Baillie Gifford & Co’s Merck MRK Stock Holding History

Baillie Gifford & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-148
Closed -$15.7K – 388
2023
Q1 		$15.7K Hold
148
– – ﹤0.01% 362
2022
Q4 		$16.4K Hold
148
– – ﹤0.01% 361
2022
Q3 		$13K Buy
+148
New +$13.2K ﹤0.01% 383

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co's MRK Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Merck (MRK) in Q2 2023, closing a stake of 148 shares — an estimated $15.7K sold.

Baillie Gifford & Co first reported a position in MRK in Q3 2022 and held it in 3 quarters. The position peaked at $16.4K in Q4 2022. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 148 Merck shares in Q2 2023, an estimated $15.7K.
  • Baillie Gifford & Co first reported a position in Merck in Q3 2022 and held it in 3 quarters.
  • Baillie Gifford & Co's Merck position peaked at $16.4K in Q4 2022.
  • 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.